newsfilter
← Latest News
Business Wire·

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026

Late-breaking oral presentation will highlight initial clinical results evaluating azer-cel, an allogeneic "off-the-shelf" CD19-directed CAR T-cell therapy, in patients with progressive multiple